Individuals with diabetes are at a significantly higher risk of developing cardiovascular disease (CVD) and often present with “silent” ischemia, meaning they may suffer a myocardial infarction without experiencing typical chest pain. The 2018 Clinical Practice Guidelines provide specific criteria for when—and how—to screen for coronary artery disease (CAD) to ensure resources are used effectively.
This practice exam tests your ability to identify which patients require routine screening (e.g., resting ECG) versus those who require further investigation (e.g., stress testing) based on their symptom profile and risk factors.
Key Concepts Covered in This Exam:
The “Silent” Threat: Understanding that a large proportion of people with diabetes will have no symptoms prior to a fatal or nonfatal myocardial infarction.
Resting ECG Guidelines: Identifying who should receive a baseline resting ECG and how often it should be repeated (e.g., every 3 to 5 years) for patients with specific risk factors.
Indications for Stress Testing: Recognizing that routine stress testing is not recommended for asymptomatic individuals, but is indicated for those with typical or atypical cardiac symptoms, or associated diseases like peripheral artery disease (PAD).
Assessment of Prognosis: Knowing when exercise stress testing is useful for assessing prognosis in high-risk individuals versus when functional imaging might be preferred.
Referral Criteria: Determining when a patient should be referred to a cardiac specialist for further evaluation.
